Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 16, Pages 9048
Publisher
MDPI AG
Online
2021-08-23
DOI
10.3390/ijms22169048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug survival in the treatment of generalized pustular psoriasis: a retrospective multicenter study
- (2021) Christian Kromer et al. Dermatologic Therapy
- Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists
- (2021) Bruce Strober et al. Dermatology and Therapy
- Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study
- (2021) Ulrich Mrowietz et al. Dermatology and Therapy
- An update on genetic basis of generalized pustular psoriasis (Review)
- (2021) Jiahong Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
- (2021) Siew Eng Choon et al. BMJ Open
- Childhood generalized pustular psoriasis: successful long‐term treatment with adalimumab
- (2020) Katharina Hansel et al. Dermatologic Therapy
- Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis
- (2020) Silke Frey et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Autoinflammatory Keratinization Diseases (AiKDs): Expansion of Disorders to Be Included
- (2020) Masashi Akiyama Frontiers in Immunology
- Spesolimab: A Novel Treatment for Pustular Psoriasis
- (2020) Kayadri Ratnarajah et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol
- (2020) Yoko Mizutani et al. JOURNAL OF DERMATOLOGY
- Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease
- (2020) Marta Vergnano et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases
- (2020) Stefan Haskamp et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Generalized pustular psoriasis – dawn of a new era in targeted immunotherapy
- (2020) Ruth Neuhauser et al. EXPERIMENTAL DERMATOLOGY
- Biologics in the treatment of pustular psoriasis
- (2020) Wen-Ming Wang et al. Expert Opinion On Drug Safety
- IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis
- (2020) Jérémie D Goldstein et al. Life Science Alliance
- “Autoinflammatory psoriasis”—genetics and biology of pustular psoriasis
- (2020) Ranjitha Uppala et al. Cellular & Molecular Immunology
- Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis
- (2019) Jing Guo et al. Drug Design Development and Therapy
- Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
- (2019) Hervé Bachelez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes
- (2019) Shuai Shao et al. FASEB JOURNAL
- Development of herpes zoster during infliximab treatment for pediatric generalized pustular psoriasis: A case report
- (2019) Wenjuan Chen et al. Dermatologic Therapy
- Risankizumab: First Global Approval
- (2019) Kate McKeage et al. DRUGS
- An update on generalized pustular psoriasis
- (2019) Melinda J. Gooderham et al. Expert Review of Clinical Immunology
- Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects
- (2019) Takuya Takeichi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
- (2018) K Furue et al. ACTA DERMATO-VENEREOLOGICA
- Pustular psoriasis and related pustular skin diseases
- (2018) H. Bachelez BRITISH JOURNAL OF DERMATOLOGY
- The genetic basis for most patients with pustular skin disease remains elusive
- (2018) R. Mössner et al. BRITISH JOURNAL OF DERMATOLOGY
- Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review
- (2018) Alexander Boehner et al. EXPERIMENTAL DERMATOLOGY
- Clinical and genetic differences between pustular psoriasis subtypes
- (2018) Sophie Twelves et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Systemic Monotherapy Treatments for Generalized Pustular Psoriasis: A Systematic Review
- (2018) Linghong Linda Zhou et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Generalized Pustular Psoriasis Induced by Infliximab in a Patient With Inflammatory Bowel Disease
- (2018) Dalal Almutairi et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin
- (2018) Masashi Akiyama et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study
- (2018) Shigetoshi Sano et al. JOURNAL OF DERMATOLOGY
- Unopposed IL-36 Activity Promotes Clonal CD4 + T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis
- (2018) Akiko Arakawa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work
- (2018) Po-Han Ho et al. JOURNAL OF DERMATOLOGY
- Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
- (2018) Hideki Fujita et al. JOURNAL OF DERMATOLOGY
- Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
- (2018) Jason E. Hawkes et al. JOURNAL OF IMMUNOLOGY
- Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China
- (2018) Zhongtao Li et al. MEDICINE
- Anti-IL17 therapies for psoriasis
- (2018) Annika Silfvast-Kaiser et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study
- (2018) Akimichi Morita et al. JOURNAL OF DERMATOLOGY
- Regulation and function of interleukin-36 cytokines
- (2017) Esen Yonca Bassoy et al. IMMUNOLOGICAL REVIEWS
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders
- (2017) Yun Liang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoinflammatory keratinization diseases
- (2017) Masashi Akiyama et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
- (2017) Andrew Johnston et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research
- (2017) Toshihiro Ito et al. JOURNAL OF DERMATOLOGY
- European consensus statement on phenotypes of pustular psoriasis
- (2017) A.A. Navarini et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations
- (2017) Takuya Takeichi et al. JAMA Dermatology
- Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study
- (2016) K. Yamasaki et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful response in a case of severe pustular psoriasis after interleukin-1β inhibition
- (2016) P. Skendros et al. BRITISH JOURNAL OF DERMATOLOGY
- Tumor Necrosis Factor-alpha Induced Protein 3 Interacting Protein 1 Gene Polymorphisms and Pustular Psoriasis in Chinese Han Population
- (2016) Jian-Wen Han et al. CHINESE MEDICAL JOURNAL
- Generalized pustular psoriasis treated with ustekinumab
- (2016) E. R. Storan et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)
- (2016) Hidehisa Saeki et al. JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study
- (2016) Shinichi Imafuku et al. JOURNAL OF DERMATOLOGY
- Adalimumab administration after infliximab therapy is a successful treatment strategy for generalized pustular psoriasis
- (2016) Ai Matsumoto et al. JOURNAL OF DERMATOLOGY
- AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production
- (2016) Satveer K. Mahil et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines
- (2016) Conor M. Henry et al. Cell Reports
- Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless ofIL36RNMutation Status
- (2016) Akiko Arakawa et al. JAMA Dermatology
- Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
- (2015) Ting-Shun Wang et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
- (2015) B. Mansouri et al. BRITISH JOURNAL OF DERMATOLOGY
- An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
- (2015) Lynda Grine et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Juvenile generalized pustular psoriasis with IL36RN mutation treated with short-term infliximab
- (2015) Junwei Pan et al. Dermatologic Therapy
- IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
- (2015) Safia Hussain et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical features and course of generalized pustular psoriasis in Korea
- (2015) Hyunju Jin et al. JOURNAL OF DERMATOLOGY
- Identification of Two Loci Associated with Generalized Pustular Psoriasis
- (2015) Zheng Zhang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris
- (2015) Dorottya M. Berki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
- (2015) Cem Gabay et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Successful use of infliximab as first line treatment for severe childhood generalized pustular psoriasis
- (2015) V. Tsang et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Childhood Generalized Pustular Psoriasis: Longtime Remission With Combined Infliximab and Methotrexate Treatment
- (2015) Andrea Skrabl-Baumgartner et al. PEDIATRIC DERMATOLOGY
- AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking
- (2014) Niovi Setta-Kaffetzi et al. AMERICAN JOURNAL OF HUMAN GENETICS
- CARD14 c.526G>C (p.Asp176His) Is a Significant Risk Factor for Generalized Pustular Psoriasis with Psoriasis Vulgaris in the Japanese Cohort
- (2014) Kazumitsu Sugiura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
- (2014) Andrea Saggini et al. Journal of Immunology Research
- Successful Treatment of Generalized Pustular Psoriasis With the Interleukin-1-Receptor Antagonist Anakinra: Lack of Correlation With IL1RN Mutations
- (2013) Manuelle Viguier ANNALS OF INTERNAL MEDICINE
- Successful therapy with anakinra in a patient with generalized pustular psoriasis carryingIL36RNmutations
- (2013) U. Hüffmeier et al. BRITISH JOURNAL OF DERMATOLOGY
- Rapid Downregulation of Innate Immune Cells, Interleukin-12 and Interleukin-23 in Generalized Pustular Psoriasis with Infliximab in Combination with Acitretin
- (2013) M.M. Tang et al. DERMATOLOGY
- Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia
- (2013) Siew Eng Choon et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- IL36RN Mutations in Generalized Pustular Psoriasis: Just the Tip of the Iceberg?
- (2013) Francesca Capon JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Majority of Generalized Pustular Psoriasis without Psoriasis Vulgaris Is Caused by Deficiency of Interleukin-36 Receptor Antagonist
- (2013) Kazumitsu Sugiura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
- (2013) Andrew L. Croxford et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- First Clinical Description of an Infant With Interleukin-36-Receptor Antagonist Deficiency Successfully Treated With Anakinra
- (2013) L. Rossi-Semerano et al. PEDIATRICS
- PSORS2 Is Due to Mutations in CARD14
- (2012) Catherine T. Jordan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Familial Pityriasis Rubra Pilaris Is Caused by Mutations in CARD14
- (2012) Dana Fuchs-Telem et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Interleukin 1 Receptor Antagonist Deficiency Presenting as Infantile Pustulosis Mimicking Infantile Pustular Psoriasis
- (2012) Kira Minkis et al. ARCHIVES OF DERMATOLOGY
- Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Acute Generalized Pustular Psoriasis
- (2012) Manuelle Viguier ARCHIVES OF DERMATOLOGY
- Mutation Analysis of theIL36RNGene in 14 Japanese Patients with Generalized Pustular Psoriasis
- (2012) Muhammad Farooq et al. HUMAN MUTATION
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation
- (2012) Amanda Robinson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Deficiency of Interleukin-1 Receptor Antagonist Responsive to Anakinra
- (2012) Charlotte Schnellbacher et al. PEDIATRIC DERMATOLOGY
- Clinical and Laboratory Features in Acute Generalized Pustular Psoriasis
- (2011) João Borges-Costa et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
- (2011) Alexandros Onoufriadis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: Description of two unrelated cases from Brazil
- (2011) Adriana A. Jesus et al. ARTHRITIS AND RHEUMATISM
- IL-36R ligands are potent regulators of dendritic and T cells
- (2011) S. Vigne et al. BLOOD
- Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity
- (2011) Jennifer E. Towne et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Flare of pustular psoriasis after initiating ustekinumab therapy
- (2011) Kurt S. Wenk et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008
- (2011) Hidetoshi TAKAHASHI et al. JOURNAL OF DERMATOLOGY
- Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
- (2011) Yijun Carrier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis
- (2010) E. Daudén et al. BRITISH JOURNAL OF DERMATOLOGY
- Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
- (2010) P. ETTEHADI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis
- (2010) Sylvia H. Kardaun et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
- (2010) Angelique N. Collamer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- CARMA1-mediated NF-κB and JNK activation in lymphocytes
- (2009) Marzenna Blonska et al. IMMUNOLOGICAL REVIEWS
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus
- (2009) Sreelatha Reddy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - a therapeutic challenge
- (2008) Martina Kucharekova et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now